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Polychlorinated biphenyls (PCBs) and diox-
ins are persistent environmental pollutants
that occur in the environment. They have
varying inﬂuences on the human body. Some
harmful inﬂuences of prenatal and/or postna-
tal exposure to PCBs and dioxins on the neu-
rodevelopment of infants have previously
been shown. Longitudinal studies have also
been performed in both low-level (back-
ground-level) dioxin-contaminated areas and
high-level contaminated areas to demonstrate
the effects of these pollutants on the neurode-
velopment of children.
Dozens of studies in background-level con-
taminated areas have been performed since the
latter half of the 1980s, such as the North
Carolina (USA) study (Gladen and Rogan
1991; Gladen et al. 1988, 2000; Rogan and
Gladen 1991; Rogan et al. 1986), the
Netherlands two-cities study (Huisman et al.
1995a, 1995b; Koopman-Esseboom et al.
1996; Lanting et al. 1998; Patandin et al. 1999;
Vreugdenhil et al. 2002a, 2002b, 2004a,
2004b), the Düsseldorf, Germany, study
(Walkowiak et al. 2001; Winneke et al. 1998),
and the U.S. 11-cities study (Daniels et al.
2003; Gray et al. 2005). The Bayley Scales of
Infant Development (BSID) or the BSID sec-
ond edition (BSID-II) was used in all of these
studies to evaluate infants’ mental or motor
development. As a result, the prenatal and/or
postnatal exposure was shown to have a signiﬁ-
cant negative association with motor develop-
ment during infancy, whereas significant
associations were not found in young children
(Gladen and Rogan 1991; Gladen et al. 1988;
Koopman-Esseboom et al. 1996; Patandin
et al. 1999; Rogan and Gladen 1991;
Vreugdenhil et al. 2002a, 2004a). On the other
hand, only one study showed a signiﬁcant neg-
ative association between postnatal exposure
and the cognitive development of young chil-
dren (Walkowiak et al. 2001). In addition,
another study showed a positive association
between prenatal exposure and motor develop-
ment during infancy in some of the diverse
study sites across the United States (Daniels
et al. 2003).
Thus, consistent results relating to the
influence of background-level dioxin expo-
sure on children’s development have not
been obtained. Longnecker et al. (2003) sug-
gested that interpretation of human data
regarding low-level, early-life PCB exposure
and subsequent neurodevelopment was prob-
lematic because levels of exposure were not
similarly quantiﬁed across studies.
In Japan, Tada and Nakamura (2000)
examined the mental development of 1-year-
old breast-fed infants and bottle-fed infants
and reported that their mental development
was within a normal range. However, this
report was not based on detailed developmen-
tal tests such as BSID. Nagayama et al. (2004)
examined the association between hexachloro-
cyclohexane, heptachlor epoxide, chlordane,
dieldrin, dichlorodiphenyltrichloroethane
(DDT), PCBs, or dioxin in breast milk and
the development of infants at 10 months. In
that study, the authors evaluated the associa-
tions using the Enjohji Scales of Infant
Development and reported that a signiﬁcant
negative association existed between PCBs
and the development of comprehension. The
developmental tests that were used in these
two studies were different from those of previ-
ous studies, and it was not possible to perform
detailed evaluations. An additional problem
was that detailed exposure measurements had
not been performed in these studies.
The aim of the present study was to exam-
ine the inﬂuence of environmental chemicals
such as PCBs and dioxins on the mental and
motor development of infants of the next gen-
eration in Sapporo, Japan. Consequently, we
carried out detailed measurements of the levels
of PCBs and dioxins in the mothers’ peripheral
blood and performed neurodevelopmental
assessments of their 6-month-old infants using
BSID-II to examine the inﬂuence of prenatal
exposure of these pollutants on the neuro-
development of infants.
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Several studies have shown that prenatal and/or postnatal background-level exposure to environ-
mental chemicals, such as polychlorinated biphenyls (PCBs) and dioxins, induces adverse effects on
the neurodevelopment of children. However, other studies have not detected any harmful inﬂu-
ences on neurodevelopment. Furthermore, except in western countries, no developmental tests have
been carried out in relation to detailed assessment of exposure to PCBs and dioxins. In this study
(the Hokkaido Study on Environment and Children’s Health), the effect of prenatal exposure to
background levels of PCBs and dioxins on infant neurodevelopment in Japan/Sapporo was eluci-
dated. The associations between the total or individual isomer level of PCBs and dioxins in 134
Japanese pregnant women’s peripheral blood and the mental or motor development of their
6-month-old infants were evaluated using the second edition of the Bayley Scales of Infant
Development. The mean level of total toxicity equivalency quantity (TEQ) was 18.8 (4.0–51.2)
pg/g lipid in blood of 134 mothers. After adjustment for potential confounding variables, the total
TEQ value was shown not to be signiﬁcantly associated with mental developmental index (MDI) or
psychomotor developmental index (PDI). However, the levels of one polychlorinated dibenzo-p-
dioxin (PCDD) isomer, total PCDDs, and total PCDDs/polychlorinated dibenzofurans (PCDFs)
were signiﬁcantly negatively associated with MDI, and the levels of two PCDD isomers and three
PCDF isomers were significantly negatively associated with the PDI. In conclusion, the back-
ground-level exposure of several isomers of dioxins during the prenatal period probably affects the
motor development of 6-month-old infants more than it does their mental development.
Key words: dioxins, infant development, maternal blood, polychlorinated biphenyls (PCBs), pre-
natal exposure. Environ Health Perspect 114:773–778 (2006). doi:10.1289/ehp.8614 available via
http://dx.doi.org/ [Online 15 December 2005]Materials and Methods
Study population. We recruited pregnant
women between July 2002 and July 2004
from the Sapporo Toho Hospital in
Hokkaido, Japan (this study became known
as the Hokkaido Study on Environment and
Children’s Health). All the subjects were
native Japanese and were resident in Sapporo
and the surrounding areas. The subjects com-
pleted the self-administered questionnaire
survey after the second trimester during their
last pregnancy. The questionnaire provided
information relating to their dietary habits,
exposure to chemical compounds in their
daily life and at their work site, home envi-
ronment, smoking, and medical histories of
themselves and their partners. The prenatal
information of the mothers and their children
was collected from their medical records. This
study was conducted with all the subjects’
written informed consent and was approved
by the institutional ethical board for epidemi-
ologic studies at Hokkaido University
Graduate School of Medicine. 
Exposure measures. A 40-mL blood sam-
ple was taken from the maternal peripheral
vein after the second trimester during their
last pregnancy. When we were not able to
take mother’s blood due to the mother’s ane-
mia during pregnancy, we took the blood
during hospitalization after delivery. All sam-
ples were stored at –80°C until analysis.
The concentrations of PCBs and dioxins in
the maternal blood were measured using high-
resolution gas chromatography/high-resolution
mass spectrometry (HRGC/HRMS) equipped
with a solvent-cut large-volume injection sys-
tem (SGE Ltd., Victoria, Australia) at Fukuoka
Institute of Health and Environmental
Sciences. The gas chromatograph was an
Agilent 6890 (Agilent Technologies Inc., Palo
Alto, CA, USA) equipped with an AutoSpec-
Ultima NT (Micromass Ltd., Manchester,
UK). The levels of PCBs and dioxins were

















furan (OCDF); four non-ortho PCBs:
3,3´,4´,4´-tetracholorobiphenyl (TCB) (con-
gener 77), 3,4,4´,5-TCB (congener 81),
3,3´,4,4´,5-pentachlorobiphenyl (PeCB) (con-
gener 126), 3,3´,4,4´,5,5´-hexachlorobiphenyl
(HxCB) (congener 169); eight mono-ortho
PCBs: 2,3,3´4,4´-PeCB (congener 105),
2,3,4,4´,5-PeCB (congener 114), 2,3´,4,4´,5-
PeCB (congener 118), 2´,3,4,4´,5-PeCB (con-
gener 123), 2,3,3´,4,4´,5-HxCB (congener
156), 2,3,3´,4,4´,5´-HxCB (congener
157), 2,3´,4,4´5,5´-HxCB (congener 167),
2,3,3´,4,4´,5,5´-heptachlorobiphenyl (HpCB)
(congener 189); and two di-ortho PCBs:
2,2´3,3´,4,4´,5-HpCB (congener 170),
2,2´,3,4,4´,5,5´-HpCB (congener 180)], and
the total toxicity equivalency quantity (TEQ)
levels were calculated (Iida and Todaka 2003;
Todaka et al. 2003). Furthermore, for several
subjects, 68 PCBs (including mono-ortho
PCBs), which remained behind in the blood,
were measured using HRGC/HRMS.
Developmental measures. We used BSID-
II (Bayley 1993) to assess the infants’ mental
and psychomotor development (mental,
motor) at 6 months of age. BSID-II is a
developmental test tool that is standardized
for use in the United States and is most
widely used as an infant assessment instru-
ment in both clinical and research settings in
the United States. The BSID-II mental scale
assesses the age-appropriate children’s level of
cognitive, language, and personal/social devel-
opment. The motor scale assesses fine and
gross motor development. Mental and motor
scores are based on the calibration scale from
raw score and are represented as index scores.
The mean values of the mental developmental
index (MDI) and the psychomotor develop-
mental index (PDI) were 100, and the stan-
dard deviation was 15. Although BSID-II has
a lot of strengths and weaknesses (Bayley
1993), it is a most useful test to measure the
present attainment of developmental abilities
of normal children (Bradley-Johnson 2001).
Because BSID-II was not standardized in
Japan, we translated a BSID-II manual in con-
sultation with a manual for BSID, which was
used in the development study reported by
Kato et al. (1987, 1988). The children were
brought to the community center in Sapporo,
where they were tested in a quiet, private room
in the presence of the parent(s) by one exam-
iner. The development evaluation was per-
formed by three occupational therapists who
have clinical experience in the ﬁeld of develop-
mental disabilities. The examiners were
unaware of the infants’ PCB and dioxin expo-
sure levels. First, for all examined children, the
scoring was performed by the examiner who
performed the examination, and then the scor-
ing was double-checked by two other examiners
based on a video that recorded the examination. 
We investigated the environmental condi-
tions of the subjects using the questionnaire
of home environment devised by Anme et al.
(1997).
Data analysis. We used the following eligi-
bility criteria for analysis of subjects: no serious
illnesses or complications during pregnancy
and delivery, singleton babies born at term
(37–42 weeks’ gestation), Apgar score of > 7 at
1 min, infants without congenital anomalies or
diseases, and BSID-II completed.
We performed multiple-regression analysis
to examine the association between BSID-II
scores (MDI, PDI) and the levels of PCBs and
dioxins in maternal blood. The levels of PCBs
and dioxins in maternal blood were logarithmi-
cally transformed, and the analysis was
adjusted for gestational age (days), smoking
during pregnancy, and caffeine intake during
pregnancy (milligrams per day). When we
Nakajima et al.
774 VOLUME 114 | NUMBER 5 | May 2006 • Environmental Health Perspectives




Age (years) 31.1 ± 4.7a
Educational level (years)
≤ 9 5 (3.7)
10–12 47 (35.1)
13–16 80 (59.7)
≥ 17 2 (1.5)
Economic status: annual income (yen)
< 3,000,000 21 (15.7)
3,000,000–5,000,000 60 (44.8)
5,000,000–7,000,000 37 (27.6)
7,000,000–10,000,000 13  (9.7)
> 10,000,000 3 (2.2)
Worked during pregnancy 22 (16.4)
Smoked during pregnancy 18 (13.4)
Fish intake during pregnancy 
Inshore ﬁsh
Rarely/never 8 (6.0)
< 1 time/week 67 (50.0)
1–4 times/week 58 (43.3)
≥ 5 times/week 1 (0.7)
Deep-sea ﬁsh
Rarely/never 2 (1.5)
< 1 time/week 54 (40.3)
1–4 times/week 78 (58.2)
≥ 5 times/week 0
Caffeine intake during pregnancy  140.6 ± 91.5a
(mg/day)
Alcohol intake before pregnancy  19.7 ± 71.9a
(g/day)
Alcohol intake during pregnancy  0.9 ± 2.6a
(g/day)
Blood sampling period 
During pregnancy 86 (64.2)





Gestational age (days) 277.3 ± 8.1a
Birth weight (g) 3124.8 ±329.1a
Length (cm) 48.2 ± 2.2a
Head circumference (cm) 33.4 ± 1.2a
First-born 67  (50.0)
Duration of breast-feeding, ≥3 months 78 (58.2)
Age at testing (days) 187.0 ± 4.4a
BSID-II mental index score: MDI  91.9 ± 5.8a
BSID-II motor index score: PDI 89.3 ± 10.5a
Index of Child Care Environmentb 22.7 ± 2.4a
aMean ± SD. bA perfect score is 30 points.examined the levels of PCBs and dioxins
among blood sampling time (during pregnancy
and after delivery) by the Mann-Whitney test,
there were signiﬁcant differences in the levels
of OCDD (p < 0.001), 1,2,3,4,6,7,8-HpCDD
(p < 0.001), total PCDDs (p < 0.01), and total
PCDDs/PCDFs (p < 0.05) (data not shown).
So the blood sampling time was adjusted
in multiple regression analysis. Results were
considered signiﬁcant if p < 0.05.
Results
One hundred thirty-ﬁve mother–infant pairs
fulfilled the determined eligibility criteria of
this study; they completed exposure measure-
ments and BSID-II. One pair was excluded
from the study because the PCB and dioxin
levels in the maternal blood were extremely
high. So, in total, 134 mother–infant pairs
were included in the study.
Characteristics of mothers and infants
are presented in Table 1. The mean (± SD)
maternal age was 31.1 ± 4.7 years; 13.4% of
mothers continued smoking during pregnancy.
Forty-four percent of mothers ate inshore ﬁsh
during pregnancy at least once per week, and
58.2% of mothers ate deep-sea fish during
pregnancy at least once per week. Fifty percent
of infants were ﬁrst-born, and 58.2% of infants
had been breast-fed > 3 months. The mean
scores of MDI and PDI were 91.9 ± 5.8 and
89.3 ± 10.5, respectively. Both values were
lower than the standardized score.
The relationships between MDI and PDI
scores and the subjects’ characteristics are pre-
sented in Table 2. For mothers’ characteristics,
caffeine intake during pregnancy was signiﬁ-
cantly negatively associated with PDI scores (r =
–0.177, p = 0.04). For infants’ characteristics,
gestational age (days) was signiﬁcantly positively
associated with MDI scores (r = 0.178, p =
0.039) and PDI scores (r = 0.289, p = 0.001).
The levels of PCBs and dioxins (picogram
per gram lipid) in maternal blood are presented
in Table 3. For subjects with a level below the
detection limit, we used a value equal to half the
detection limit (Longnecker et al. 2000). The
means (ranges) of levels of total PCDD/PCDF
TEQ, total coplanar PCB TEQ, and total
TEQ were 11.9 (2.1–31.2), 6.9 (1.1–22.2),
and 18.8 (4.0–51.2) pg TEQ/g lipid, respec-
tively. The mean level of dioxins in this study
was slightly lower than that of the subjects in
other studies of domestic areas with ages simi-
lar to that in this study. In addition, the
median level of PCB-153 in the maternal
blood of 64 subjects in this study was 22.9
ng/g lipid, which was lower than that in the
previous study (Longnecker et al. 2003).
Table 4 shows the results of the multiple
regression analysis of the association between
the levels of PCBs and dioxins in maternal
blood and MDI and PDI scores. After adjust-
ment for blood sampling time, gestational age
(days), smoking during pregnancy, and caf-
feine intake during pregnancy (milligrams per
day), PCDD isomer 1,2,3,4,6,7,8-HpCDD
(p < 0.05), total PCDDs (p < 0.01), and total
PCDDs/PCDFs (p < 0.05) were signiﬁcantly
negatively associated with MDI. On the other
hand, PCDD isomers 1,2,3,7,8,9-HxCDD (p
< 0.05) and 1,2,3,4,6,7,8-HpCDD (p < 0.01),
2,3,7,8-TCDF (p < 0.05), 1,2,3,7,8-PeCDF
(p < 0.05), and PCDF isomer 1,2,3,6,7,8-
HxCDF (p < 0.05) were significantly nega-
tively associated with PDI. The total levels of
PCBs and dioxins were not signiﬁcantly asso-
ciated with PDI, and the TEQ values were not
signiﬁcantly associated with MDI or PDI.
Discussion
To the best of our knowledge, this is the ﬁrst
report to investigate the association between the
early neurodevelopment of infants and the total
level and individual isomer level of Japanese
pregnant women’s blood at background levels.
As a result, there was no association between
the TEQ value of the maternal blood and the
PCB/dioxin level, whereas the levels of several
isomers of dioxins were signiﬁcantly negatively
associated with mental or motor development.
The total levels of PCDDs or PCDDs/PCDFs
were signiﬁcantly associated with mental devel-
opment, whereas the levels of several speciﬁc
isomers of PCDDs or PCDFs were associated
with motor development.
In this study, the results of BSID-II were
used as a neurodevelopment evaluation test
for infants. The mean (± SD) MDI and PDI
scores were 91.9 ± 5.8 and PDI 89.3 ± 10.5,
respectively. Both scores were lower than the
standardized scores (100). Because there is a
cultural difference and a verbal difference
between Japan and the United States, the BSID-
II must be used with care in Japan. In particular,
we should use standardized “classiﬁcation” to
judge how to treat or intervene with a child.
However, the ﬁrst BSID edition was used in
PCBs, dioxins, and child development
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Table 2. BSID-II mental (MDI) and psychomotor (PDI) development scores for infants in relation to mother
and infant characteristics (n = 134).
MDI PDI
Characteristic No. Mean ± SD p-value Mean ± SD p-value
Maternal characteristics
Age (years) r = 0.042 0.626 r = –0.059 0.496
Educational level 
≤ 12 years 52 92.2 ± 5.0 0.647 89.8 ± 10.8 0.676
≥ 13 years 82 91.7 ± 6.2 89.0 ± 10.4
Economic status: annual income
< 5,000,000 yen 81 91.6 ± 5.8 0.444 89.4 ± 10.4 0.875
≥ 5,000,000 yen 53 92.3 ± 5.8 89.1 ± 10.7
Worked during pregnancy
No 112 91.5 ± 5.7 0.107 89.1 ± 10.3 0.697
Yes 22 93.7 ± 6.0 90.1 ± 11.8
Smoked during pregnancy
No 116 92.0 ± 5.8 0.469 89.8 ± 10.6 0.183
Yes 18 90.9 ± 5.8 86.2 ± 9.1
Inshore ﬁsh intake during pregnancy
< 1 time/week; rarely/never 75 91.6 ± 6.0 0.612 88.9 ± 11.3 0.670
≥ 1 time/week 59 92.2 ± 5.5 89.7 ± 9.4
Deep-sea ﬁsh intake during pregnancy
< 1 time/week; rarely/never 56 92.6 ± 5.3 0.198 89.9 ± 10.6 0.542
≥ 1 time/week 78 91.3 ± 6.0 88.8 ± 10.5
Caffeine intake during pregnancy (mg/day) r = –0.063 0.470 r = –0.177 0.040*
Alcohol intake before pregnancy (g/day) r = –0.050 0.564 r = –0.099 0.256
Alcohol intake during pregnancy (g/day) r = 0.137 0.114 r = 0.011 0.898
Blood sampling time
During pregnancy 86 92.0 ± 5.5 0.767 88.8 ± 10.3 0.472
After delivery 48 91.7 ± 6.3 90.2 ± 10.9
Child characteristics
Sex
Male 68 91.6 ± 5.8 0.595 87.8 ± 9.9 0.084
Female 66 92.1 ± 5.8 90.9 ± 10.9
Gestational age (days) r = 0.178 0.039* r = 0.289 0.001**
Birth weight (g) r = 0.103 0.237 r = 0.086 0.323
Length (cm) r = 0.058 0.506 r = –0.060 0.489
Head circumference (cm) r = 0.071 0.416 r = –0.015 0.862
First-born
Yes 67 92.3 ± 6.1 0.356 89.7 ± 10.5 0.617
No 67 91.4 ± 5.5 88.8 ± 10.6
Duration of breast-feeding, ≥ 3 months
Yes 78 92.1 ± 6.0 0.557 89.9 ± 10.5 0.422
No 56 91.5 ± 5.5 88.4 ± 10.5
Index of Child Care Environment r = –0.016 0.855 r = –0.122 0.161
Student’s t-test, Pearson’s correlation coefﬁcient test: *p < 0.05; **p < 0.01.Japan for developmental evaluation of chil-
dren. In addition, Oka et al. (2005) reported
that there was a high correlation between
BSID-II and the Kyoto Developmental Test
that was standardized in Japan. A study in
Taiwan stated that reproducibility was high in
BSID-II, even if there were cultural differ-
ences (Huang et al. 2000). Evaluation of
neurodevelopment was limited to 6-month-
old infants, and all the examiners scored all
the infant subjects. Therefore, the BSID-II
scores of the subjects in this study were
directly comparable with each other.
The mean (range) level of PCBs and dioxins
in maternal blood was 18.8 (4.0–51.2) pg
TEQ/g lipid in this study, lower than that of
subjects in studies in other domestic areas
(Watanabe 2000). Longnecker et al. (2003)
reported that interpretation of human data
regarding low-level, early-life PCB exposure
and subsequent neurodevelopment was prob-
lematic because levels of exposure were not
similarly quantiﬁed across studies. Therefore,
the PCB levels across studies of neurodevelop-
ment were expressed in a uniform manner
using the median level of PCB-153 in mater-
nal pregnancy serum. The median PCB-153
level in the U.S. 11-cities, the Düsseldorf, the
Netherlands two-cities, and the North
Carolina studies ranged from 80 to 140 ng/g
lipid, which were within the range of back-
ground levels. The median level of PCB-153
in the maternal blood of 64 subjects in this
study was 22.9 ng/g lipid, which was clearly a
lower contamination level in comparison with
the other studies.
In this study, there was no signiﬁcant asso-
ciation between the TEQ values of maternal
blood PCB/dioxin level and mental and motor
development, whereas there were significant
negative associations with the levels of some
isomers of dioxins and mental and motor
development. The total levels of PCDDs or
PCDDs/PCDFs were signiﬁcantly associated
with mental development, whereas the levels of
several speciﬁc isomers of PCDDs or PCDFs
were associated with motor development.
There are many previous studies (Gladen et al.
1988; Koopman-Esseboom et al. 1996;
Walkowiak et al. 2001) that show negative
influences on the motor development of
infants and young children rather than on their
mental development. Although we used only
the total PCB level or TEQ value as the expo-
sure index in previous studies, we measured
various levels of isomers of PCBs or dioxins in
this study. In this study, there were no signiﬁ-
cant negative associations between the total lev-
els of PCBs and dioxins and mental or motor
development, whereas there were significant
negative associations between motor develop-
ment and levels of isomers of PCDDs and
PCDFs. In this respect, it was impossible to
explain the mechanism of our ﬁndings because
there were few human or animal experimental
studies investigating the association between
individual isomer levels of PCBs and dioxins
and neurodevelopment. So, at low-level expo-
sure, total, and total TEQ values had only a
minimal effect on mental and motor develop-
ment. However, we found that several speciﬁc
chemical compounds would have an adverse
inﬂuence on motor development, whereas total
PCDDs or total PCDDs/PCDFs would have
an adverse inﬂuence on mental development.
Gray et al. (2005) reported that the level
of total PCBs in mothers in their study,
which did not show a significantly negative
association with the level of total PCBs and
the outcome, was similar to those in other
studies in which an adverse effect was found.
On the other hand, the mixture of PCBs in
their specimens was unusual compared with
that in other studies. Levels of nonquantitated
PCBs may also have varied in biologically sig-
niﬁcant ways. Thus, they speculated that they
might have had a relatively benign mixture if
the composition of PCBs affected neurotoxic-
ity. Therefore, the minimal effect of total and
total TEQ values on mental and motor devel-
opment in this study might be caused by the
composition of PCBs and dioxins.
Nakajima et al.
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Table 3. Level of PCBs and dioxins (pg/g lipid) in maternal blood (n = 134).
Detection Geometric
limita Mean mean Minimum 25thb 50thb 75thb Maximum
PCDDs
2,3,7,8-TCDD 1.0 1.1 0.9 ND ND 1.1 1.4 3.1
1,2,3,7,8-PeCDD 1.0 4.4 3.9 ND 3.1 4.2 5.4 11.9
1,2,3,4,7,8-HxCDD 2.0 1.8 1.6 ND ND ND 2.3 13.6
1,2,3,6,7,8-HxCDD 2.0 15.5 13.7 2.4 10.4 14.5 18.3 43.6
1,2,3,7,8,9-HxCDD 2.0 2.3 1.9 ND ND 2.2 3.2 7.4
1,2,3,4,6,7,8-HpCDD 2.0 26.0 24.0 9.6 18.2 23.3 31.5 69.7
OCDD 4.0 504.7 468.0 169.6 352.2 467.4 601.2 1491.5
PCDFs
2,3,7,8-TCDF 1.0 0.7 0.6 ND ND ND ND 2.5
1,2,3,7,8-PeCDF 1.0 0.6 ND ND ND ND ND 2.2
2,3,4,7,8-PeCDF 1.0 6.5 5.8 1.4 4.5 6.0 7.7 19.9
1,2,3,4,7,8-HxCDF 2.0 2.6 2.3 ND ND 2.6 3.3 6.5
1,2,3,6,7,8-HxCDF 2.0 3.0 2.6 ND 2.2 2.8 3.7 8.6
2,3,4,6,7,8-HxCDF 2.0 1.1 1.1 ND ND ND ND 5.0
1,2,3,7,8,9-HxCDF 2.0 ND ND ND ND ND ND ND
1,2,3,4,6,7,8-HpCDF 2.0 3.1 2.4 ND ND 2.5 3.4 15.8
1,2,3,4,7,8,9-HpCDF 2.0 ND ND ND ND ND ND ND
OCDF 4.0 2.1 ND ND ND ND ND 11.0
Non-ortho PCBs
3,3´,4´,4´-TCB (77) 10.0 13.2 11.9 ND 10.5 12.8 16.1 37.2
3,4,4´,5-TCB (81) 10.0 ND ND ND ND ND ND ND
3,3´,4,4´,5-PeCB (126) 10.0 42.2 36.0 ND 26.0 37.0 54.9 141.7
3,3´,4,4´,5,5´-HxCB (169) 10.0 31.9 28.3 ND 21.5 29.2 36.6 85.9
Mono-ortho PCBs
2,3,3´4,4´-PeCB (105) 10.0 1637.6 1418.8 256.1 976.2 1423.9 2044.1 5420.8
2,3,4,4´,5-PeCB (114) 10.0 407.2 353.3 79.3 248.6 363.9 488.5 1442.6
2,3´,4,4´,5-PeCB (118) 10.0 6582.0 5691.3 1293.2 3912.5 5803.5 8192.7 20196.9
2´,3,4,4´,5-PeCB (123) 10.0 127.8 109.4 24.3 70.3 113.7 154.5 458.6
2,3,3´,4,4´,5-HxCB (156) 10.0 2213.2 1942.1 441.5 1307.2 1982.9 2737.5 6427.8
2,3,3´,4,4´,5´-HxCB (157) 10.0 557.2 485.4 85.1 333.3 507.0 675.4 1782.7
2,3´,4,4´,5,5´-HxCB (167) 10.0 806.3 702.0 158.6 507.6 739.9 1005.0 2275.3
2,3,3´,4,4´,5,5´-HpCB (189) 10.0 244.7 209.2 ND 138.1 222.7 312.0 625.8
Di-ortho PCBs
2,2´,3,3´,4,4´,5-HpCB (170) 10.0 4518.4 3881.1 1104.9 2570.7 4155.7 5622.0 13620.5
2,2´,3,4,4´,5,5´-HpCB (180) 10.0 13996.8 12063.7 2704.4 8392.9 12813.5 17957.1 41110.1
Total
Total PCDDs 547.8 511.1 192.8 389.5 508.9 646.9 1602.4
Total PCDFs 42.7 21.1 10.4 16.6 20.6 24.5 2877.3
Total PCDDs/PCDFs 590.5 538.1 206.4 408.3 526.8 675.1 3726.3
Total non-ortho PCBs 91.4 83.7 27.4 64.2 85.5 110.3 269.9
Total mono-ortho PCBs 12575.9 11042.2 2832.8 7812.5 11471.6 15238.9 36382.2
Total coplanar PCBs 12667.3 11131.1 2860.2 7868.6 11554.7 15352.0 36536.1
Total 13257.8 11770.9 3311.1 8431.7 12053.1 15845.5 37267.2
WHO-98c
Total PCDD TEQ 7.7 7.0 1.6 5.3 7.2 9.4 20.7
Total PCDF TEQ 4.2 3.8 1.2 2.9 3.8 5.0 12.4
Total PCDD/PCDF TEQ 11.9 10.9 2.8 8.2 11.2 14.0 31.2
Total non-ortho PCB TEQ 4.5 3.8 0.6 2.7 3.9 5.9 15.0
Total mono-ortho PCB TEQ 2.5 2.2 0.6 1.6 2.2 2.9 7.2
Total coplanar PCB TEQ 6.9 6.1 1.1 4.4 6.2 8.6 22.2
Total TEQ 18.8 17.2 4.0 13.4 17.8 23.4 51.2
Abbreviations: ND, nondetectable; WHO, World Health Organization.
aFor subjects with a level below the detection limit, we used a value equal to half the detection limit. bPercentiles. cThe cal-
culation of TEQ was estimated based on the toxic equivalent factor values proposed by the WHO (Van den Berg 1998).In this study, we performed multiple-
regression analysis to examine the association
between BSID-II scores (MDI, PDI) and total
and individual isomer level of PCBs and diox-
ins. Because we performed 45 statistical tests for
MDI or PDI, this study had a multiple-testing
problem. If we performed the Bonferroni
adjustment for addressing the multiple-testing
problem, all the signiﬁcances would have disap-
peared. Furthermore, this study has a small sam-
ple size. These are the limitations of this study.
However, because the measurement of
PCBs and dioxins is highly complicated and is
too expensive, it is difﬁcult to measure these
compounds in a large number of subjects. In
recent studies of the associations between back-
ground-level exposure to PCBs and dioxins
and infant neurodevelopment (Koopman-
Esseboom et al. 1996; Walkowiak et al. 2001),
the sample size was similar to our study.
However, no studies have measured isomer
levels of PCBs and dioxins to analyze the
associations between individual isomer levels
and infant neurodevelopment. Because expo-
sure to PCBs and dioxins can be reduced to
prevent their adverse effects on children’s devel-
opment, even if the α error rate rises to some
extent, we consider it important to catch these
adverse effects on children’s development.
Therefore, we believe that analysis of the associ-
ations between PCBs and dioxins and chil-
dren’s development in this study was valuable.
In Japan, Nakai et al. (2004) also per-
formed a prospective study to elucidate the
inﬂuence of an endocrine-disrupting chemical
on the neurodevelopment of children.
Humans are the main source of various chem-
ical compounds that are known pollutants,
and food seems to be the main source of
PCBs and dioxins in background-level expo-
sure. Because the intake of marine products,
such as fish or iodine, in an island country
such as Japan would be greater than in west-
ern countries, a risk evaluation based on
domestic dioxin/PCB data is important.
Vreugdenhil et al. (2002b) pointed out that
an improving tendency was shown in children
of school age, even if there was a significant
negative association between endocrine-
disrupting chemical level and neurodevelop-
ment of children during infancy. Breast-feeding
and a good home environment are regarded as
important factors that improve the inﬂuence.
Additional studies are needed to elucidate these
results still further.
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